![](/img/cover-not-exists.png)
A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study
Patrizia Vici, Giuseppe Colucci, Francesco Giotta, Domenico Sergi, Gianfranco Filippelli, Pasquale Perri, Claudio Botti, Enrico Vizza, Armando Carpino, Laura Pizzuti, Agnese Latorre, Diana GiannarelliVolume:
30
Language:
english
DOI:
10.1186/1756-9966-30-39
Date:
December, 2011
File:
PDF, 415 KB
english, 2011